Mylan Inc.

🇺🇸United States
Ownership
-
Established
1961-01-01
Employees
35K
Market Cap
-
Website
https://www.mylan.com/

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

First Posted Date
2011-09-02
Last Posted Date
2022-06-13
Lead Sponsor
Mylan Inc.
Target Recruit Count
579
Registration Number
NCT01427725
Locations
🇯🇵

Research facility ID ORG-000216, Aichi, Japan

🇯🇵

Research facility ID ORG-000215, Aichi, Japan

🇯🇵

Research facility ORG-000096, Aichi, Japan

and more 186 locations

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

First Posted Date
2011-09-02
Last Posted Date
2022-06-10
Lead Sponsor
Mylan Inc.
Target Recruit Count
24
Registration Number
NCT01427712
Locations
🇯🇵

Site reference ID/Investigator # 96698, Aichi, Japan

🇯🇵

Research facility ORG-000972, Ehime, Japan

🇯🇵

Site Reference ID/Investigator# 65530, Kagawa, Japan

and more 18 locations

Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

First Posted Date
2010-04-01
Last Posted Date
2022-03-31
Lead Sponsor
Mylan Inc.
Target Recruit Count
466
Registration Number
NCT01097005
Locations
🇯🇵

Site Reference ID/Investigator# 36482, Hyogo, Japan

🇯🇵

Site Reference ID/Investigator# 36465, Inzai, Japan

🇯🇵

Site Reference ID/Investigator# 36483, Ishikawa, Japan

and more 56 locations

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

First Posted Date
2008-03-12
Last Posted Date
2022-09-29
Lead Sponsor
Mylan Inc.
Target Recruit Count
220
Registration Number
NCT00634166
Locations
🇺🇸

University of South Alabama Medical Center, Mobile, Alabama, United States

🇺🇸

Loyola University Medical Center, Maywood, Illinois, United States

🇺🇸

John's Hopkins Burn Center, Baltimore, Maryland, United States

and more 6 locations
© Copyright 2024. All Rights Reserved by MedPath